Results 11 to 20 of about 86,432 (312)

Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.

Journal of the American College of Cardiology, 2020
BACKGROUND The SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) randomized 2,521 patients with moderate heart failure (HF) to amiodarone, placebo drug, or implantable cardioverter-defibrillator (ICD) therapy.
J. Poole, B. Olshansky, D. Mark, Jill Anderson, George Johnson, A. Hellkamp, L. Davidson-Ray, D. Fishbein, R. Boineau, K. Anstrom, P. Reinhall, D. Packer, Kerry L Lee, G. Bardy   +13 more
semanticscholar   +1 more source

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

Europace, 2016
Laurent Fauchier, Sana M Al-Khatib, Alejandro Cuesta   +2 more
exaly   +2 more sources

Pacemakers and implantable cardioverter defibrillators – general and anesthetic considerations

Brazilian Journal of Anesthesiology, 2014
A pacemaking system consists of an impulse generator and lead or leads to carry the electrical impulse to the patient's heart. Pacemaker and implantable cardioverter defibrillator codes were made to describe the type of pacemaker or implantable ...
Amy G. Rapsang, Prithwis Bhattacharyya
doaj   +3 more sources

IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR

RA Journal Of Applied Research, 2020
Salwa Cheraou
openaire   +2 more sources

Editorial: Developments in cardiac implantable electronic device therapy: how can we improve clinical implementation?

Frontiers in Cardiovascular Medicine, 2023
GRAPHICAL ABSTRACTCIED, cardiac implantable electronic devices; CRT, cardiac resynchronization therapy; CRT-D, cardiac resynchronization therapy defibrillator; EA, electroanatomical; ICD, implantable cardioverter defibrillator; LBB, left bundle branch ...
Mate Vamos, Julia W. Erath, Alexander P. Benz, Alexander P. Benz, Gabor Z. Duray   +4 more
doaj   +1 more source

Subcutaneous Implantable Cardioverter Defibrillator [PDF]

Circulation: Arrhythmia and Electrophysiology, 2012
Implantable cardioverter-defibrillators (ICDs) represent a very effective therapy for primary and secondary prevention of sudden cardiac death (SCD). However, implantation of endocardial leads using a transvenous approach is associated with significant procedural and long term complications.
Christopher P, Rowley, Michael R, Gold
openaire   +2 more sources

First-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-Defibrillator.

JACC Clinical Electrophysiology, 2020
OBJECTIVES The aim of this study was to evaluate the safety and performance of an extravascular (EV) implantable cardioverter-defibrillator (ICD). BACKGROUND Limitations of existing transvenous and subcutaneous ICD systems include lead reliability and ...
I. Crozier, H. Haqqani, E. Kotschet, D. Shaw, A. Prabhu, N. Roubos, J. Alison, I. Melton, R. Denman, Tina Lin, A. Almeida, B. Portway, Robert T. Sawchuk, A. Thompson, L. Sherfesee, S. Liang, L. Lentz, P. Degroot, A. Cheng, D. O'Donnell   +19 more
semanticscholar   +1 more source

Implantable cardioverter-defibrillator utilization [PDF]

Europace, 2011
Following the recent publication of our article1 concerning the European paradox with regard to implantable cardioverter defibrillator (ICD) device utilization in Europe (markedly lower device utilization in Europe compared with the USA), which updated several previous reports,2,3 …
John, Camm, Seah, Nisam
openaire   +2 more sources

Inevitable high-dose irradiation to lead of implantable cardioverter defibrillator in small cell lung cancer: a case report

Journal of Medical Case Reports, 2019
Background Radiotherapy has been shown to cause malfunction of implantable cardioverter-defibrillators, and there are few studies of implantable cardioverter-defibrillators and radiotherapy.
Jeong Won Lee, Ki Ho Seol
doaj   +1 more source

Reticular telangiectatic erythema: case report and literature review

Dermatology Practical & Conceptual, 2015
Background: Reticular telangiectatic erythema is a benign cutaneous reaction that may occur in patients who have received a subcutaneous implantable cardioverter-defibrillator.
Bryce D. Buetler, Philip R. Cohen
doaj   +1 more source